MENU
MEHCQ
Stock ticker: OTC
PRICE
CHANGE
CAPITALIZATION

23andMe Holding (MEHCQ) Ownership - Who owns 23andMe Holding?

23andMe Holding Co is a consumer-facing healthcare technology company, involved in the sale of direct-to-consumer personal genome services, or PGS, through DNA collection kits shipped via mail... Show more

Details

Group
Domestic Stock Funds
Category
Medical Specialties
Capitalization
115.67M
P/E Ratio
N/A
Total Cash
39.83M
Projected Growth
N/A
Total Debt
42.6M
Revenue
174.9M
Risk (Beta)
2.59
Dividend Yield
N/A
Total Cash/Share
1.45
Total Debt/Equity
N/A
Revenue/Share
6.60 USD as % of share price

Fundamentals

MEHCQ
Capitalization
116M
P/E Ratio
N/A
Risk (Beta)
2.59
Dividend Yield
N/A
Total Cash
39.8M
Total Cash/Share
1.45
Total Debt
42.6M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.60%
Revenue
175M
ROE
N/A
Book Value
-42.86M
P/B Ratio
2.20
Cash Flow
N/A
Earnings
-8.95
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3K
Current Ratio
0.53
Current Revenue Per Employee
95920.76
Dividends Per Share - Security
N/A
EBITDA
-130.77M
Float
N/A
Float - Current
N/A
Gross Income Margin
53.23
Revenue To Assets
-91.85
Shares Held By Institutions
3.63M
Shares Outstanding - Current
27.5M
Total Liabilities
187M
Total Volume MTD
N/A
Value
1
Gain YTD
29.231
View a ticker or compare two or three
MEHCQ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details